Market Insights

Total compensation, which includes wages and benefits, climbed 2.7 percent over past 12 months.

The greatest decline in treatment volumes in 2017 was for prescription opioids, which fell by more than 33 percent during the past two years.

The blame game could still happen to you, but if you're aware of your clients' unique situations, it might not.

The blame game could still happen to you, but if you're aware of your clients' unique situations, it might not.

Direxion, a $13.6 billion money manager, is starting an ETF. Here's what you need to know.

Generic drugs account for more than 90 percent of U.S. prescriptions. Overcapacity and the emergence of big purchasing groups have slammed manufacturers' margins.